Literature DB >> 23053999

Investigation of microRNA expression changes in HepG2 cell line in presence of URG4/URGCP and in absence of URG4/URGCP suppressed by RNA interference.

Yavuz Dodurga1, G Nilufer Yonguc, Cigir Biray Avci, Gulseren Bagci, Cumhur Gunduz, N Lale Satiroglu-Tufan.   

Abstract

Hepatocellular carcinoma (HCC) originates from liver cells and is one of the most common malignant cancers in the world. microRNAs (miRNA), are single strand non-coding RNA molecules with the length of 18-25 nucleotides. miRNAs play an important role in the development of HCC, i.e., miRNAs have a significant impact on multistep hepatocellular carcinogenesis including cellular migration and invasion. URG4/URGCP (up-regulated gene-4/upregulator of cell proliferation) is up-regulated in the presence of HBxAg and has been identified and characterized by Satiroglu-Tufan et al. The full-length URG4/URGCP is 3.607 kb. Overexpression of URG4/URGCP in the presence of HBV X protein may function as a putative oncogene that significantly contributes to multi-step hepatocarcinogenesis. In this study, we aimed to investigate potential miRNA expression changes in HepG2 cell line model system in the presence of URG4/URGCP and in the absence of URG4/URGCP, which was suppressed by RNA interference. To functionally characterize URG4/URGCP, independent cultures of HepG2 cells were stably transfected with pcDNA3 or pcDNA3-URG4/URGCP. Relative quantification of whole genome miRNAs was analyzed by RT-PCR using human whole genome miRNA qPCR profiling kits. Among the 1,034 human miRNAs investigated by the arrays, 77 miRNAs were up-regulated and nine miRNAs were down-regulated in the presence of URG4/URGCP. In conclusion, we have analyzed miRNA profiles in HepG2 cells in presence or absence of URG4/URGCP gene using RNA interference. Some of these miRNAs may play roles in URG4/URGCP gene related disease development through the regulation of different signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053999     DOI: 10.1007/s11033-012-2019-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Hepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survival.

Authors:  N Lale Satiroglu Tufan; Zhaorui Lian; Jie Liu; Jingbo Pan; Patrick Arbuthnot; Michael Kew; Marcy M Clayton; Minghua Zhu; Mark A Feitelson
Journal:  Neoplasia       Date:  2002 Jul-Aug       Impact factor: 5.715

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis.

Authors:  Z Lian; J Pan; J Liu; S Zhang; M Zhu; P Arbuthnot; M Kew; M A Feitelson
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

6.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

7.  RNA interference-mediated URG4 gene silencing diminishes cyclin D1 mRNA expression in HepG2 cells.

Authors:  N L Satiroglu-Tufan; Y Dodurga; D Gok; A Cetinkaya; M A Feitelson
Journal:  Genet Mol Res       Date:  2010-08-10

8.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

9.  Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

Authors:  Jinmai Jiang; Yuriy Gusev; Ileana Aderca; Teresa A Mettler; David M Nagorney; Daniel J Brackett; Lewis R Roberts; Thomas D Schmittgen
Journal:  Clin Cancer Res       Date:  2008-01-15       Impact factor: 12.531

10.  Alteration of drug metabolizing enzymes in sulphite oxidase deficiency.

Authors:  Begum Tutuncu; Vural Kuçukatay; Sevki Arslan; Barbaros Sahin; Asli Semiz; Alaattin Sen
Journal:  J Clin Biochem Nutr       Date:  2012-03-30       Impact factor: 3.114

View more
  6 in total

1.  Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk.

Authors:  Chao Ou; Hai-Ping Zheng; Jian-Jia Su; Ji Cao; Guo-Jian Li; Le-Qun Li
Journal:  Afr Health Sci       Date:  2014-03       Impact factor: 0.927

2.  Regulation of URG4/URGCP and PPARα gene expressions after retinoic acid treatment in neuroblastoma cells.

Authors:  Cigir Biray Avci; Yavuz Dodurga; Gulsah Gundogdu; Hasan Onur Caglar; Vural Kucukatay; Cumhur Gunduz; N Lale Satiroglu-Tufan
Journal:  Tumour Biol       Date:  2013-07-03

3.  Profiles of miRNAs in serum in severe acute drug induced liver injury and their prognostic significance.

Authors:  Mark W Russo; Nury Steuerwald; Harry J Norton; William E Anderson; David Foureau; Naga Chalasani; Robert J Fontana; Paul B Watkins; Jose Serrano; Herbert L Bonkovsky
Journal:  Liver Int       Date:  2016-11-29       Impact factor: 5.828

4.  Serological identification of URGCP as a potential biomarker for glioma.

Authors:  Ling-Chao Chen; Hai-Yan Zhang; Zhi-Yong Qin; Yang Wang; Ying Mao; Yu Yao; Liang-Fu Zhou
Journal:  CNS Neurosci Ther       Date:  2013-12-06       Impact factor: 5.243

5.  Downregulation of miR-16 via URGCP pathway contributes to glioma growth.

Authors:  Liang Hong; Ouyang Qing; Zhou Ji; Zhang Chengqu; Chen Ying; Cui Hao; Xu Minhui; Xu Lunshan
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

6.  MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.

Authors:  Hui Lin; Zhi-Ping Huang; Jiao Liu; Yun Qiu; Yuan-Ping Tao; Meng-Chao Wang; Hui Yao; Ke-Zhu Hou; Fang-Ming Gu; Xuan-Fu Xu
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.